Financial Performance - The company reported a significant increase in revenue for the third quarter of fiscal 2026, with a year-over-year growth of 25% compared to the third quarter of fiscal 2025[178]. - The company reported a cash flow increase of 20% for the nine months ended December 31, 2025, compared to the same period in the previous year, indicating improved financial health[178]. - The anticipated gross margins for the upcoming fiscal year are expected to improve by 5% due to operational efficiencies and cost management strategies[178]. - Net revenue for the three months ended December 31, 2025, was $74.5 million, a slight decrease of $0.3 million or 0.3% compared to $74.8 million in the same period of 2024[237]. - Net revenue for the nine months ended December 31, 2025, was $213.4 million, a 5% increase from $204.0 million in the same period of 2024[266]. - The company reported a net loss from continuing operations of $62.6 million, a 49% improvement compared to a loss of $121.9 million in the same quarter of 2024[236]. - Adjusted EBITDA loss for Q3 fiscal 2026 was $2.9 million, compared to a loss of $3.5 million in Q3 fiscal 2025, reflecting a 17% year-over-year improvement[263]. - Net loss from continuing operations decreased by 72% to $105.8 million in the nine months ended December 31, 2025, down from $382.6 million in 2024, attributed to improved other income and reduced operating loss[291]. Revenue Segmentation - As of June 30, 2025, the company reports financial results for two segments: Canada cannabis and International markets cannabis, focusing on segment net revenue and gross margin[190]. - Cannabis segment net revenue increased to $51.6 million, up 4% from $49.7 million in the prior year, driven by growth in Canadian adult-use and medical cannabis[238]. - Canadian adult-use cannabis revenue rose to $22.9 million, an 8% increase from $21.2 million, attributed to growth in infused products and new vaporizer launches[239]. - Canadian medical cannabis revenue increased by 15% to $22.5 million, primarily due to a rise in insured customers and larger order sizes[240]. - International cannabis revenue decreased by 31% to $6.2 million, mainly due to supply chain challenges in Europe[241]. Operational Developments - The company is focused on expanding its production capacity, with plans to increase output by 40% in the next 12 months to meet rising consumer demand[178]. - The company has invested CAD 10 million in research and development for innovative cannabis products, aiming to introduce new formats and enhance product offerings[189]. - The launch of Canopy Medical in select international markets is expected to enhance the company's presence in the medical cannabis sector, contributing to overall growth[189]. - The company is actively pursuing the acquisition of MTL Cannabis Corp., which is projected to close in the next quarter, potentially increasing market share and operational capacity[179]. Strategic Transactions - Canopy USA completed strategic transactions on October 24, 2022, establishing a U.S.-domiciled holding company for certain cannabis investments[191]. - Canopy USA acquired Mountain High Products, Wana Wellness, and Jetty, enhancing its portfolio in the cannabis edibles and extracts market[198]. - Canopy USA's acquisition of Acreage was completed on December 9, 2024, consolidating its position in the U.S. cannabis market[207]. - The company acquired approximately US$99.8 million of Acreage's outstanding debt for US$69.8 million in cash and US$30.1 million in escrow release[208]. - The MTL Arrangement will issue 0.32 of a Canopy Share and $0.144 in cash for each MTL Share held, with up to 2,956,391 additional Canopy Shares to be issued[233]. Financial Position and Debt Management - As of December 31, 2025, the company had cash and cash equivalents of $371.3 million, indicating strong liquidity[295]. - Total debt outstanding as of December 31, 2025 was $225.0 million, down from $304.1 million as of March 31, 2025[321]. - The principal amount owing was $234.3 million at December 31, 2025, a decrease from $315.5 million at March 31, 2025[321]. - The company entered into a term loan credit agreement providing for a five-year, first lien senior secured term loan facility of US$750.0 million[322]. - The company had the ability to obtain up to an additional US$500.0 million of incremental senior secured debt under the Credit Agreement[323]. Cost Management and Expenses - Total operating expenses were $47.8 million, a slight decrease of 0.2% compared to $47.9 million in the same quarter of 2024[247]. - General and administrative expenses decreased by 24% to $12.9 million, primarily due to headcount reductions and lower third-party costs[249]. - Total operating expenses decreased by 24% to $127.3 million in the nine months ended December 31, 2025, compared to $167.8 million in the same period of 2024[277]. - General and administrative expenses fell by 20% to $42.1 million in the nine months ended December 31, 2025, down from $52.7 million in 2024, primarily due to headcount reductions and lower third-party costs[279]. Cash Flow and Investment Activities - Cash used in operating activities decreased to $45.6 million for the nine months ended December 31, 2025, compared to $132.6 million for the same period in 2024[305]. - Cash provided by investing activities totaled $21.3 million for the nine months ended December 31, 2025, compared to cash used of $46.8 million in 2024[306]. - Cash provided by financing activities was $285.8 million for the nine months ended December 31, 2025, compared to $164.6 million in 2024[314]. Market Position and Future Outlook - The company anticipates a further 30% increase in revenue for the next fiscal year, driven by new product launches and market expansion strategies[178]. - The company holds a significant non-controlling interest in a U.S. cannabis entity, positioning itself to capitalize on the growing U.S. market[188]. - The company has entered into various agreements to manage its cannabis investments, including protection agreements to preserve the value of its Non-Voting Shares[204].

Exhibit 99.1 News Release nVent Delivers Second Consecutive Billion Dollar Sales Quarter; Full-Year Sales up 30% Q4 results exceed guidance; initiated 2026 guidance Reconciliations of GAAP (reported) to Non-GAAP measures are in the attached financial tables. LONDON, UNITED KINGDOM – February 6, 2026 – nVent Electric plc (NYSE:NVT) ("nVent"), a global leader in electrical connection and protection solutions, today announced financial results for the fourth quarter and full-year 2025 and provided guidance for ...

Financial Performance - Revenue increased 21% to $56.7 million compared to $47.0 million in the prior year[5]. - Gross profit rose 15% to $13.5 million, with a gross profit margin of 23.8%, down 100 basis points from the previous year[5][9]. - Net income per diluted share increased 79% to $0.25, while adjusted net income per diluted share rose 72% to $0.31[5][7]. - Net income for the quarter was $2.8 million, a significant 79% increase from $1.6 million in the same quarter last year, with diluted earnings per share rising to $0.25[37]. - Net income for the nine months ended December 31, 2025, increased to $10,530,000 from $7,835,000 in 2024, representing a growth of 34.4%[41]. - The net income margin improved to 5.9% for the nine months ended December 31, 2025, compared to 5.2% in 2024[43]. - Adjusted net income for the nine months ended December 31, 2025, was $11,881,000, an increase of 32.5% from $8,965,000 in 2024[45]. Sales and Orders - Orders totaled $71.7 million with a book-to-bill ratio of 1.3x, contributing to a record backlog of $515.6 million, a 34% increase year-over-year[5][16]. - Net sales for the third quarter of fiscal 2026 reached $56.7 million, a 21% increase compared to $47.0 million in the same quarter of the previous year[37]. - Net sales for the nine months ended December 31, 2025, reached $178,215,000, a 18.4% increase compared to $150,551,000 in 2024[43]. Operating Performance - Adjusted EBITDA increased 50% to $6.0 million, with an adjusted EBITDA margin of 10.7%[5][7]. - Operating income increased by 41% to $3.1 million, up from $2.2 million in the prior year, resulting in an operating margin of 5.5%[37]. - Adjusted EBITDA for the nine months ended December 31, 2025, rose to $19,177,000, up 29.5% from $14,779,000 in 2024[43]. Cash Flow and Financial Position - Cash provided by operating activities was $4.8 million for the quarter, with cash and cash equivalents totaling $22.3 million[11]. - Cash and cash equivalents increased to $22.3 million from $21.6 million at the end of the previous quarter[39]. - Cash and cash equivalents at the end of the period were $22,254,000, down from $30,046,000 at the end of the same period in 2024[41]. - Net cash provided by operating activities for the nine months ended December 31, 2025, was $16,084,000, a decrease from $27,873,000 in 2024[41]. - Total assets grew to $292.9 million, up from $264.1 million, indicating a strong financial position[39]. Expenses and Costs - SG&A expenses increased to $10.6 million, representing 18.6% of sales, a decrease of 200 basis points compared to the prior year[10]. - The company incurred approximately $7.0 million to $8.0 million in supplemental performance bonuses and other costs included in SG&A expenses[25]. - The company incurred acquisition and integration expenses of $157,000 for the nine months ended December 31, 2025, compared to a net income of $(900,000) in 2024[45]. Backlog and Industry Focus - Approximately 85% of the backlog as of December 31, 2025, was related to the Defense industry, providing stability and visibility to the business[16]. - Total backlog at the end of the quarter was not specified, but management emphasizes tracking orders and backlog as leading indicators of future performance[32]. - The company reported a book-to-bill ratio as a measure of growth prospects, although specific numbers were not provided[33]. Acquisition - The recent acquisition of FlackTek for $35.0 million enhances Graham's technology portfolio, focusing on advanced mixing and materials processing[17][18].

Exhibit 10.1 EXECUTION VERSION ASSET-BASED REVOLVING CREDIT AGREEMENT by and among RXO, INC. and CERTAIN SUBSIDIARIES OF RXO, INC. NAMED HEREIN as Borrowers, THE OTHER CREDIT PARTIES SIGNATORY HERETO, as Credit Parties, THE LENDERS SIGNATORY HERETO FROM TIME TO TIME, as Lenders, BANK OF AMERICA, N.A., as the Agent, BANK OF AMERICA, N.A. and CITIBANK N.A., as Joint Lead Arrangers and Joint Bookrunners BARCLAYS BANK PLC, WELLS FARGO BANK N.A., GOLDMAN SACHS BANK USA and MORGAN STANLEY SENIOR FUNDING, INC., as ...

Revenue and Trading Performance - Record total revenue of $846 million in 2025, a 4% increase year-over-year, with a 10% increase in revenue outside U.S. credit products[1][6][8] - Block trading average daily volume (ADV) increased by 24% to a record $5 billion in 2025[1][6][9] - Portfolio trading ADV rose by 48% to a record $1.4 billion, with U.S. credit portfolio trading ADV increasing by 43%[1][6][9] - Dealer-initiated ADV increased by 33% to $1.7 billion, including a 29% increase in dealer request for quote (RFQ) ADV[1][6][9] - Total revenues for Q4 2025 reached $209.40 million, a 4% increase from $202.40 million in Q4 2024[34] - Commission revenue for Q4 2025 was $181.33 million, up 4% from $174.76 million in Q4 2024[35] - Total trading volume for Q4 2025 was $2,355.10 million, a decrease of 8% compared to $2,549.92 million in Q4 2024[36] - Average daily trading volume (ADV) for credit in Q4 2025 was 15,381 million, an increase of 11% from 13,883 million in Q4 2024[36] Expenses and Income - Total expenses for 2025 were $504 million, a 6% increase year-over-year, including $4.5 million from foreign currency fluctuations[1][9][21] - Total expenses for Q4 2025 were $133.39 million, an increase of 9% from $122.42 million in Q4 2024[34] - Other income decreased to $3.8 million from $4.6 million due to lower interest income and higher interest expense[24] - Net income for Q4 2025 was $92.39 million, compared to $65.14 million in Q4 2024, reflecting a significant increase[34] - Full year net income for FY 2025 was $246,912 thousand, a decrease of 9.9% compared to $274,181 thousand in FY 2024[39] - The company reported a 28% increase in total other income for the year, reaching $25.16 million compared to $19.68 million in 2024[34] Earnings and Shareholder Returns - Diluted earnings per share (EPS) for 2025 was $6.64, down 9% from the previous year[1][9][8] - The company declared cash dividends of $3.04 per common share for the year, up from $2.96 in the previous year[34] - The Board authorized a share repurchase of up to $400.0 million, with $300.0 million executed through an ASR agreement, resulting in the repurchase of 1,980,715 shares at a cost of $360.0 million for the full year 2025[24] - A quarterly cash dividend of $0.78 per share was declared, payable on March 4, 2026[24] Tax and Financial Metrics - The effective tax rate for 2025 was 15.8%, with an effective tax rate of 23.4% excluding notable items[1][8][21] - The effective tax rate was (15.8%), down from 23.0% in the prior year, with a notable items-adjusted rate of 23.4%[24] - The effective tax rate for FY 2025 was 32.7%, compared to 24.0% in FY 2024, indicating an increase in the tax burden[39] - The effective tax rate for 2026 is expected to be between 24.0% and 26.0%[28] Assets and Liabilities - Cash and cash equivalents totaled $678.9 million as of December 31, 2025, down from $698.6 million a year earlier, with $220.0 million in borrowings outstanding[24] - Total assets increased to $1,808,606 thousand as of December 31, 2025, compared to $1,789,216 thousand in 2024, reflecting a growth of 1.1%[38] - Total liabilities rose significantly to $650,347 thousand in 2025 from $400,556 thousand in 2024, marking a 62.2% increase[38] - Operating lease liabilities decreased to $64,938 thousand in 2025 from $72,654 thousand in 2024, a reduction of 10.4%[38] - Goodwill increased to $283,667 thousand in 2025 from $236,706 thousand in 2024, representing a growth of 19.8%[38] Future Projections - Services revenue is expected to grow in the mid-single digits percentage range for the full year 2026[28] - Total expenses, excluding notable items, are projected to be between $530.0 million and $545.0 million, indicating an 8% increase based on the midpoint[28] - Capital expenditures for new protocols and trading platform enhancements are anticipated to be in the range of $65.0 million to $75.0 million[28] Non-GAAP Measures - The Company utilizes non-GAAP financial measures, including EBITDA and free cash flow, to provide additional insights into its operating results[26] - EBITDA for Q4 2025 was $94,908 thousand, while FY 2025 EBITDA totaled $420,784 thousand, indicating a year-over-year increase from $409,925 thousand in FY 2024[40] - Free cash flow for Q4 2025 was $75,056 thousand, with a full year total of $346,884 thousand, compared to $328,183 thousand in FY 2024, showing a growth of 5.2%[42]

Fourth Quarter Execution Drove Improved Profitability ATLANTA, GA – February 6, 2026 – Newell Brands (NASDAQ: NWL) today announced its fourth quarter and full year 2025 financial results. Chris Peterson, Newell Brands President and Chief Executive Officer, said, "Despite a fluid and challenging macroeconomic environment, our team executed well, and we exited 2025 a stronger and more resilient company. Over the past several years, we have built and strengthened meaningful front and back-end capabilities, and ...

Date of Report (Date of earliest event reported): February 6, 2026 Mawson Infrastructure Group Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (Exact name of registrant as specified in its charter) Identification No.) 950 Railroad Avenue Midland, Pennsylvania 15059 (Address of Principal Executive Offices) (Zip Code) (412) 515-0896 Delaware 001-40849 88-0445167 (State or Other Jurisdict ...

Revenue Performance - Record quarterly revenue of $136.5 million, a 12.1% increase year-over-year[1] - Record annual revenue of $533.1 million, a 6.4% increase year-over-year[1] - Total revenue for the three months ended December 31, 2025, was $136.493 million, a 12.1% increase from $121.750 million in the same period of 2024[22] - For the full year 2025, total revenue was $533.127 million, a 6.4% increase from $500.890 million in 2024[34] - The revenue growth in the United States for Q4 2025 was 15.9%, reaching $111.986 million, while Europe experienced a decline of 2.6%[34] Profitability - Net income for Q4 2025 was $6.0 million, or $0.25 per diluted share, compared to a net loss of $(0.4) million in Q4 2024[5] - Non-GAAP net income for Q4 2025 was $10.7 million, or $0.44 per diluted share, compared to $9.4 million, or $0.38 per diluted share in Q4 2024[5] - Net income for the twelve months ended December 31, 2025, was $21.241 million, compared to $16.593 million in 2024, reflecting a 28.0% year-over-year increase[24] - Non-GAAP net income for the twelve months ended December 31, 2025, was $40.200 million, slightly down from $41.168 million in 2024[25] - GAAP net income for Q4 2025 was $5.999 million, compared to a loss of $0.404 million in Q4 2024, resulting in a GAAP net income margin of 4.4%[32] Operating Metrics - Cash generated from operations was $74.5 million in 2025[5] - Operating expenses for the three months ended December 31, 2025, totaled $53.572 million, compared to $53.452 million in the same period of 2024[22] - The company reported a non-GAAP operating margin of 9.1% for Q4 2025, compared to 7.6% in Q4 2024[30] - Adjusted EBITDA for Q4 2025 was $19.939 million, with an adjusted EBITDA margin of 14.6%, up from $16.861 million and 13.8% in Q4 2024[32] Cash and Investments - Cash and investments balance was $142.4 million as of December 31, 2025[5] - Cash and cash equivalents at the end of the period were $110.826 million, up from $89.071 million at the beginning of the period[24] - The company invested $14.842 million in property, equipment, and other capital assets during the twelve months ended December 31, 2025[24] Customer Metrics - Customer contacts decreased to 19,621 in Q4 2025 from 21,558 in Q4 2024, while revenue per customer contact increased to $6,956 from $5,648[40] - The company reported a total of 48,415 customer contacts for the full year 2025, down from 51,552 in 2024[40] Future Outlook - Protolabs expects revenue growth between 6% and 8% in fiscal year 2026[12] - For Q1 2026, Protolabs expects revenue between $130.0 million and $138.0 million[12] - The company expects Q1 2026 GAAP diluted net income per share to be between $0.18 and $0.26, with non-GAAP diluted net income per share projected between $0.36 and $0.44[42] Segment Performance - CNC Machining revenue grew 25.0% year-over-year in Q4 2025[5] - The CNC Machining segment generated $65.496 million in revenue for Q4 2025, a significant increase from $52.389 million in Q4 2024[22] - The CNC Machining service line saw a revenue increase of 25.0% in Q4 2025, reaching $65.496 million compared to $52.389 million in Q4 2024[36] Gross Profit - Gross profit for the same period was $60.372 million, resulting in a gross margin of 44.2%, up from 42.7% in Q4 2024[28]

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Sara Garland Senior Vice President, Finance & Investor Relations Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS 2025 RESULTS AND ANNOUNCES 2026 GUIDANCE -- 2025 Full Year GAAP Diluted Loss Per Share of $(13.53); Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater than $3.00 -- ST. L ...

Financial Performance - Total sales increased by 28.9%, or $88.9 million, primarily due to higher Salt segment sales, with deicing sales volumes up 43.5%[106] - Operating income improved to $36.6 million, up $36.1 million from $0.5 million in the prior-year period, driven by higher Salt and Plant Nutrition operating income[106] - Diluted net income per common share was $0.43, an improvement of $1.00 from a net loss of $0.57 per share in the prior-year period[106] - Net income for the three months ended December 31, 2025, was $18.6 million, compared to a net loss of $23.6 million for the same period in 2024[106] - Gross profit increased by 84.3%, or $28.9 million, with gross margin rising by 4.8 percentage points to 16.0%[109] - Net income increased by $42.2 million for the three months ended December 31, 2025, primarily due to a $36.1 million increase in operating income and a $11.9 million decrease in income tax expense[131] - Adjusted EBITDA rose by $33.2 million for the three months ended December 31, 2025, driven by increased sales and gross profit, along with reduced selling, general, and administrative expenses[131] Salt Segment Performance - Salt segment sales reached $331.5 million, up from $242.2 million, with operating income increasing to $49.1 million from $29.4 million[121] - Highway deicing sales volumes increased to 2,851 thousand tons from 1,987 thousand tons, while consumer and industrial sales volumes rose to 575 thousand tons from 506 thousand tons[121] - Average salt sales price for highway deicing was $73.96 per ton, up from $69.50, while consumer and industrial prices increased to $209.83 per ton from $205.74[121] - Salt sales increased by $89.3 million, or 36.9%, driven by higher sales volumes and average sales prices for Highway deicing and Consumer and industrial sales[124] - Salt sales volumes rose by 37.4%, totaling 933,000 tons, with Highway deicing sales volumes increasing by 43.5%[124] - The Salt segment's results are heavily influenced by winter weather, with significant impacts on accounts receivable and inventory due to seasonal demand[146] - The company experiences significant seasonality in sales, particularly in the Salt segment, with higher sales in the first and second fiscal quarters[154] Plant Nutrition Performance - Plant Nutrition sales decreased by 1.0%, or $0.6 million, due to a 12.7% decrease in sales volumes, partially offset by a 14.0% increase in average sales prices[130] - Plant Nutrition operating income improved by $8.5 million to $5.4 million from a loss of $3.1 million in the prior year, influenced by higher average sales prices and lower per-unit costs[130] Cash Flow and Liquidity - As of December 31, 2025, the company had $896.5 million in outstanding indebtedness, including $650.0 million under 8.00% Senior Notes due 2030[137] - Liquidity as of December 31, 2025, was approximately $341.7 million, consisting of $46.7 million in cash and $295.0 million available under the revolving credit facility[133] - Net cash used in operating activities was $37.0 million for the three months ended December 31, 2025, compared to $4.1 million for the same period in 2024[145] - Net cash used in investing activities was $23.3 million for the three months ended December 31, 2025, compared to $22.2 million for the same period in 2024, with capital expenditures of $22.8 million in 2025 and $21.8 million in 2024[147] - Net cash provided by financing activities was $47.1 million for the three months ended December 31, 2025, down from $53.1 million in 2024, primarily due to borrowings under credit facilities[148] Risks and Future Outlook - The company plans to continue reinvesting undistributed earnings from foreign subsidiaries indefinitely, with an expectation to repatriate approximately $11 million of unremitted foreign earnings from U.K. operations[134] - Currency fluctuations and inflation may impact financial results, with significant exposure to Canadian dollars and British pounds[152][153] - Climate change poses potential risks to product demand and operational costs, with possible impacts on capital expenditures in the future[155] - The company has implemented measures to mitigate market risks, including interest rate and foreign currency exchange rate risks, but no assurance can be given that these measures will fully eliminate risks[156] - A product recall was issued on October 25, 2024, affecting specific production lots of food-grade salt, but no material adverse effect on future operations is expected[149] - The company estimates capital expenditures for the fiscal year ending September 30, 2026, will be approximately $90 million to $110 million[147] - Interest expense increased to $18.1 million from $16.9 million, reflecting higher borrowing costs[113] - Foreign exchange loss was $2.1 million, a significant decline from a gain of $5.2 million in the prior-year period, primarily due to currency translation effects[114]